Carcinogenesis Advance Access published online on February 28, 2008
Carcinogenesis, doi:10.1093/carcin/bgn038
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Widespread hyperplasia induced by transgenic TGF
in ApcMin mice is associated with only regional effects on tumorigenesis
1 McArdle Laboratory for Cancer Research
2 Comprehensive Cancer Center
3 Laboratory of Genetics, University of Wisconsin School of Medicine and Public Health
4 Present Address: Department of Biochemistry, University of Wisconsin, Madison, Wisconsin 53706
Corresponding Author: William F. Dove, McArdle Laboratory for Cancer Research, 1400 University Avenue, Madison, WI 53706, Phone: (608) 262-4977, Email: dove{at}oncology.wisc.edu
Using a mouse predisposed to neoplasia by a germline mutation in Apc (ApcMin), we tested whether induced hyperplasia is sufficient to increase intestinal tumor multiplicity or size in the intestine. We found that hyperplasia in the jejunum correlated with a significant increase in tumor multiplicity. However, tumor multiplicity was unchanged in the hyperplastic colon. This result indicates that even an intestine predisposed to neoplasia can, in certain regions including the colon, accommodate net increased cell growth without developing more neoplasms. Where hyperplasia correlated with increased tumor multiplicity, it did not increase the size or net growth of established tumors. This result suggests that the event linking hyperplasia and neoplasia in the jejunum is tumor establishment. Two novel observations arose in our study: the Min mutation partially suppressed both mitosis and TGF
-induced hyperplasia throughout the intestine; and zinc treatment alone increased tumor multiplicity in the duodenum of Min mice.
Key Words: Hyperplasia regionality zinc intestine tumor Apc
Received August 30, 2007; revised January 11, 2008; accepted January 29, 2008.